Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Research progress in biomarkers of pulmonary fibrosis diseases
Ming Chen
, Ming Zeng
, Xing Xuan He
Friedman Brain Institute
Genetics and Genomic Sciences
Icahn School of Medicine at Mount Sinai
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Research progress in biomarkers of pulmonary fibrosis diseases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Fibrosis Diseases
100%
Pulmonary Fibrosis
100%
Quality of Life
14%
Disease Diagnosis
14%
Therapeutic Efficacy
14%
Potential Biomarkers
14%
Effective Treatment
14%
Heme oxygenase-1 (HO-1)
14%
Screening Diagnosis
14%
Early Diagnosis
14%
Complex Etiology
14%
Surfactant Protein D (SP-D)
14%
Chronic Lung Disease
14%
Biomarkers of Effect
14%
Idiopathic Pulmonary Fibrosis
14%
Promoter Variants
14%
Silicosis
14%
MUC5B
14%
Biomarkers of Susceptibility
14%
Sphingolipid Signaling
14%
Krebs Von Den Lungen-6 (KL-6)
14%
Matrix metalloprotease-7
14%
Serum Se
14%
Medicine and Dentistry
Biological Marker
100%
Pulmonary Fibrosis
100%
Diseases
100%
Promoter Region
14%
Quality of Life
14%
Combination Therapy
14%
Chronic Lung Disease
14%
Idiopathic Pulmonary Fibrosis
14%
Metalloproteinase
14%
Heme Oxygenase 1
14%
Early Diagnosis
14%
Surfactant Protein D
14%
Silicosis
14%
Mucin 5B
14%
Sphingolipid Signaling
14%
Effective Treatment
14%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Lung Fibrosis
100%
Diseases
100%
Combination Therapy
14%
Metalloproteinase
14%
Heme Oxygenase 1
14%
Sphingolipid
14%
Surfactant Protein D
14%
Chronic Lung Disease
14%
Fibrosing Alveolitis
14%
Mucin 5B
14%
Silicosis
14%